Poster Presentations / Axolabs

Selected Poster Presentations

Oligonucleotide synthesis

Synthesis, uptake and biological activity of multimers of C-miR146a: a conjugate of CpG-rich deoxynucleotide D19 and micro-RNA miR146a (2021)

Oligonucleotide delivery

(Bio)analytics

Novel mass spectrometry-based sequencing method for modified sgRNA (2021)
Extended preclinical ocular biodistribution and pharmacodynamic profile of ISTH0 036, an antisense oligonucleotide targeting transforming growth factor beta 2 (TGF-β2) for the treatment of ophthalmic diseases (2018)
Preclinical profile of ISTH0036, a potent and selective antisense oligonucleotide targeting transforming growth factor beta 2 (TGF-β2) for the treatment of ophthalmic diseases (2015)
The analysis of a single stranded antisense oligonucleotide in plasma via lysation and hybridization with HPLC-fluorescence (2014)
Preclinical and clinical development of SYL040012 eye drops for the treatment of increased intraocular pressure associated to glaucoma (2013)

Company

Axolabs is the leading service provider for the discovery, development and manufacture of therapeutics based on DNA or RNA.

Information

Privacy Statement

Terms & Conditions of Axolabs GmbH, Kulmbach

E-Mail: info@axolabs.com

Locations

Kulmbach, Germany

Berlin, Germany

Petaluma, CA, USA

©2023 axolabs.com

Programmierung und technische Betreuung
AS-DESIGN.Werbeagentur GmbH